Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from GSK

Older Americans can get RSV vaccine this fall after speaking with their doctor, CDC says

Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first

The Independent UK · Jun 29, 2023

‘Gamechanging’ TB vaccine within reach after $500m pledge to run final trials

Joint deal between Gates Foundation and Wellcome to develop M72 jab could save 8.5 million lives and prevent 76 million cases

The Guardian - UK · Jun 28, 2023

Gonorrhea shot gets FDA fast track as resistant cases multiply

GSK Plc’s experimental gonorrhea vaccine got fast-track designation from U.S. regulators, putting the shot in position to become the first preventive for a common, often-undetected infection that’s gaining resistance to treatment.

Tribune News Service · Jun 28, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

How big pharma is using AI to untangle the language of DNA

AI-powered tools are rapidly transforming the world of drug discovery

Evening Standard · Jun 23, 2023

GSK settles lawsuit over heartburn drug allegedly linked to cancer

The drug was owned by GSK but distribution was halted and it was recalled in 2019

Wales Online · Jun 23, 2023

A+E Works With Ad Client GSK To Produce Meningitis B Awareness Film

Short features Soleil Moon Frye, Melissa Joan Hart

Multichannel News · Jun 20, 2023

Vivek Ramaswamy is threatening GOP heavyweights in the polls–but his business record doesn't live up to the hype

Yale's Sonnenfeld and Tian retrace presidential hopeful Vivek Ramaswamy's business record.

Fortune · Jun 14, 2023

Read news from The Economist, FT, and more,
with one subscription

GSK CEO Emma Walmsley says A.I. could improve Big Pharma's most 'profound' challenge: R&D inefficiency

"When we talk about health care costs, the single biggest thing we can do is innovate more.”

Fortune · Jun 1, 2023

GSK’s CEO says you need thick skin if you’re going to step into the C-suite

Emma Walmsley reflects on what it takes to lead a company through a turnaround.

Fortune · May 31, 2023

Why GSK's Emma Walmsley 'violently rejects' the idea of 'superhero' CEOs

In her mind, leadership is about inspiring collaboration.

Fortune · May 30, 2023

Being 'nature-positive' has been a hollow aim. That’s about to change

Move over, greenwashing (and greenwishing). Goodbye, vague nature goals. Enter science-based nature targets.

Fortune · May 25, 2023

Giant turbines in South Ayrshire village would power Irvine pharmaceutical giant's factory

Residents debated whether to pragmatically embrace two turbines, which would power nearby GSK, planned for Dundonald.

Daily Record · May 19, 2023

RSV vaccine for pregnant women protects their newborns but is it ready for US sale?

Federal health advisers are debating a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy

The Independent UK · May 18, 2023

AI Drug Discovery Is a $50 Billion Opportunity for Big Pharma

Artificial intelligence can shave years off the development process, and companies like Japan’s Takeda are making large investments.

Businessweek · May 9, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu · May 6, 2023

FDA approves first vaccine for respiratory syncytial virus

The FDA has approved the first vaccine for respiratory syncytial virus (RSV).

Chicago Sun-Times · May 4, 2023

FDA approves 1st RSV vaccine for older adults

After decades of failure in the quest for an RSV vaccine, doctors are anxious to finally have something to offer — especially after a virus surge that strained hospitals last fall.

LiveScience · May 4, 2023

FDA approves 1st RSV vaccine

The Food and Drug Administration has approved a vaccine for respiratory syncytial virus (RSV) for use in people ages 60 and older.

The Times of India · May 4, 2023

World's first respiratory syncytial virus vaccine gets approval: Key points to know

Pharmaceutical company GSK's RSV vaccine has been approved by the US Food and Drug Administration (FDA) to become the world's first such vaccine. Known as Arexvy, this vaccine has been approved after three clinical trials.

Get all your
news in one place.

100's of premium titles.
One news app.

Axios · May 3, 2023

FDA approves United States' first-ever RSV vaccine

GSK's RSV vaccine is approved for people aged 60 and older.

The Independent UK · May 3, 2023

US approves first vaccine for RSV after decades of attempts

The US has approved the first vaccine for RSV, shots to protect older adults

The Guardian - UK · Apr 26, 2023

New CBI boss says she is ‘profoundly sorry’ to women let down by group

Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry

Evening Standard · Apr 26, 2023

End of the road for Covid turnover, GSK says

GSK has signalled the end of the road for its Covid drug sales boom as the pharma giant eyes fresh sources of revenue to plug the hole left by the subsidence of the pandemic.

Evening Standard · Apr 26, 2023

FTSE 100 Live: ‘A radical decline in UK investment’ — London Stock Exchange boss grilled on US listings

GSK, housebuilder Persimmon and the consumer products group Reckitt Benckiser are among the blue-chips updating investors today.

The Guardian - UK · Apr 24, 2023

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

Insider UK · Apr 19, 2023

GSK workers to strike after rejecting pay offer

Workers at sites in Irvine and Montrose are set to walk out next month

1 … 10 11 12 13

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

London Stock Exchange

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.